B. Lebe Et Al. , "The clinical significance of p53, p21, and p27 expressions in rectal carcinoma," APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1, pp.38-44, 2005
Lebe, B. Et Al. 2005. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1 , 38-44.
Lebe, B., SARIOĞLU, S., SÖKMEN, S., ELLİDOKUZ, H., Fuzun, M., & Kupelioglu, A., (2005). The clinical significance of p53, p21, and p27 expressions in rectal carcinoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1, 38-44.
Lebe, BANU Et Al. "The clinical significance of p53, p21, and p27 expressions in rectal carcinoma," APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1, 38-44, 2005
Lebe, BANU Et Al. "The clinical significance of p53, p21, and p27 expressions in rectal carcinoma." APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1, pp.38-44, 2005
Lebe, B. Et Al. (2005) . "The clinical significance of p53, p21, and p27 expressions in rectal carcinoma." APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.13, no.1, pp.38-44.
@article{article, author={BANU LEBE Et Al. }, title={The clinical significance of p53, p21, and p27 expressions in rectal carcinoma}, journal={APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY}, year=2005, pages={38-44} }